Stay updated on HMPL-523 in Lymphoma Patients Clinical Trial
Sign up to get notified when there's something new on the HMPL-523 in Lymphoma Patients Clinical Trial page.

Latest updates to the HMPL-523 in Lymphoma Patients Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedRevision updated from v3.4.3 to v3.5.0.SummaryDifference0.0%

- Check17 days agoNo Change Detected
- Check24 days agoChange DetectedThe page revision was updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

- Check39 days agoChange DetectedAdded 'Results Posted' and new site details including Bergamo, Italy. Expanded Dose Escalation and Dose Expansion sections with detailed study endpoint definitions (PFS, TTR, DOR, ORR, CBR) and scheduling; removed older endpoint descriptions and some prior location text.SummaryDifference5%

- Check46 days agoChange DetectedRevision: v3.4.2 is now shown, replacing v3.4.1. This appears to be a minor site maintenance update and does not alter the study details or user-facing content.SummaryDifference0.0%

- Check53 days agoChange DetectedRevision label updated from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check60 days agoChange DetectedThe changes largely consist of cosmetic UI text adjustments and a new revision/version indicator (v3.4.0) replacing the previous version. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

Stay in the know with updates to HMPL-523 in Lymphoma Patients Clinical Trial
Enter your email address, and we'll notify you when there's something new on the HMPL-523 in Lymphoma Patients Clinical Trial page.